According to Foresight News, MEI Pharma has announced its acquisition of Litecoin. The company is collaborating with Litecoin's founder, Charlie Lee, and GSR to launch a $100 million institutional treasury strategy. This initiative aims to leverage Litecoin's potential in the financial sector, enhancing MEI Pharma's investment portfolio.
MEI Pharma Invests in Litecoin and Partners for Institutional Treasury Strategy
--・
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs.
Explore the latest crypto news
⚡️ Be a part of the latests discussions in crypto
💬 Interact with your favorite creators
👍 Enjoy content that interests you
Email / Phone number
Relevant Creator
@Binance_News